The TEL-AML1 fusion which results from a cryptic t(12;21) translocation is
the most frequently occurring genetic abnormality in childhood acute lympho
blastic leukemia (ALL) and has been associated with an excellent treatment
outcome. In the present study, we examined the FAS/BCL-2 expression profile
s and chemosensitivity of primary leukemic cells from children with newly d
iagnosed t(12;21)TEL-AML1 fusion transcript-positive versus t(12;21)TEL-AML
1 fusion transcript-negative standard risk ALL. TEL-AML1(+) ALL cells expre
ssed higher levels of the pro-apoptotic protein Fas and lower levels of the
anti-apoptotic protein Bcl2 than TEL-AML1(-) ALL cells, as determined by c
onfocal laser scanning microscopy. TEL-AML1(+) ALL cells were more sensitiv
e to the apoptosis-inducing effects of serum deprivation, dexamethasone and
vincristine than TEL-AML1(-) ALL cells. This study provides novel mechanis
tic insights regarding the chemosensitivity of TEL-AML1(+) ALL cells and pr
ovides a cogent explanation for the excellent leukemia-free survival outcom
e of children with TEL-AML1(+) ALL treated on contemporary chemotherapy pro
grams.